ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Research Reagent/N⁶-(tert-Butoxycarbonyl)-N²,N²-bis(carboxymethyl)-L-lysine
C15H26N2O8
362.38 g/mol
Research Reagent

N2,N2-BIS(CARBOXYMETHYL) N6-BOC-

CAS752200-93-4
Category
Research Reagent
Compound Class
Peptide
Primary Use
Research Compound

This compound is a protected lysine derivative featuring a bis(carboxymethyl) group at the N2 position and a tert-butoxycarbonyl (Boc) protecting group at the N6 position. It is primarily used as a building block in solid-phase peptide synthesis, enabling the incorporation of modified lysine residues into custom peptide sequences.

building block for peptide synthesisresearch reagent for modified lysine incorporation

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing N2,N2-BIS(CARBOXYMETHYL) N6-BOC-?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

ApplicationSame Use

(S)-2,6-Bis-tert-butoxycarbonylaminohexanoic acid

CAS2483-46-7

research compound

ReferenceSame Category

(1Z)-1-[2-(²H₅)Phenylhydrazinylidene]naphthalen-2(1H)-one

CAS752211-63-5

research compound

ReferenceSame Category

4-Ethynyl-N,N-dimethylbenzenamine

CAS752235-18-0

research compound

ReferenceSame Category

Methyl L-phenylalaninate hydrochloride

CAS7524-50-7

research compound

ReferenceSame Category

Sodium 2-(4-(2-hydroxyethyl)piperazin-1-yl)ethanesulfonate

CAS75277-39-3

research compound

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(2S)-2-[bis(carboxymethyl)amino]-6-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid

InChIKey

KLJVHTFKVKHTIN-JTQLQIEISA-N

SMILES

CC(C)(C)OC(=O)NCCCC[C@@H](C(=O)O)N(CC(=O)O)CC(=O)O

Synonyms (5)

—

Sourcing N2,N2-BIS(CARBOXYMETHYL) N6-BOC-?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→